Clinical Trial Update: Mineralocorticoid Receptor in the Treatment of Severe Depression [NA]

View source ↗

Summary

The clinical trial investigating mineralocorticoid receptor modulation for severe depression has completed; specific results are not provided in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Major Depression | NA | Status: COMPLETED